Here are a few of the most interesting Benitec Biopharma statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Benitec Biopharma Facts
- Website: Official Website
- Year Founded: 1997
- Headquarters: Melbourne, Australia
- Founder(s): Michael Graham
- Current Chief Executive: Jerel Banks
What is Benitec Biopharma?
Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference (RNAi) with gene therapy with a goal of providing sustained, long-lasting silencing of disease-causing genes from a single administration. Benitec is using its technology, called DNA-directed RNA interference (ddRNAi) to develop a pipeline of product candidates for the treatment of several chronic and life-threatening human diseases , including oculopharyngeal muscular dystrophy (OPMD) and hepatitis B. By combining the specificity and gene silencing effect of RNAi with gene therapy, ddRNAi has the potential to produce long-lasting silencing of disease-causing genes from a single administration, which could minimize the requirement for patients to take regular doses of medicine. (source)
Benitec Biopharma Employee Count
Number of Benitec Biopharma employees:
Last updated 7/1/19
Benitec Biopharma Revenue Totals
Benitec Biopharma annual revenue:
- FY 2019: $17.509 million
- FY 2018: $4.465 million
- FY 2017: $10.840 million
- FY 2016: $3.837 million
- FY 2015: $3.198 million
Benitec Biopharma annual net income:
- FY 2019: $4.094 million
- FY 2018: $11.640 million net loss
- FY 2017: $5.690 million net loss
- FY 2016: $24.778 million net loss
- FY 2015: $11.509 million net loss